Need to streamline research on CRISPR Gene-Editing technology: Experts
Nov 17, 2021
Bengaluru (Karnataka) [India], November 18 : The endogenous manufacturing of CRISPR components, through greater research, would make India a commercially successful country in the field of Deep Science, according to Girish Krishnamurthy, CEO & MD, Tata Medical and Diagnostics Ltd.